A detailed history of Swiss National Bank transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, Swiss National Bank holds 610,700 shares of ZBH stock, worth $67.5 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
610,700
Previous 607,200 0.58%
Holding current value
$67.5 Million
Previous $65.9 Million 0.03%
% of portfolio
0.04%
Previous 0.05%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$104.47 - $116.17 $365,645 - $406,595
3,500 Added 0.58%
610,700 $65.9 Million
Q2 2024

Aug 08, 2024

SELL
$106.25 - $130.01 $1.98 Million - $2.42 Million
-18,600 Reduced 2.97%
607,200 $65.9 Million
Q1 2024

May 07, 2024

SELL
$119.98 - $132.61 $3.32 Million - $3.67 Million
-27,700 Reduced 4.24%
625,800 $82.6 Million
Q4 2023

Feb 06, 2024

SELL
$102.72 - $121.7 $1.93 Million - $2.29 Million
-18,800 Reduced 2.8%
653,500 $79.5 Million
Q3 2023

Nov 08, 2023

SELL
$110.76 - $143.18 $9.46 Million - $12.2 Million
-85,400 Reduced 11.27%
672,300 $75.4 Million
Q2 2023

Aug 09, 2023

SELL
$126.43 - $145.6 $9.51 Million - $10.9 Million
-75,200 Reduced 9.03%
757,700 $110 Million
Q1 2023

May 10, 2023

SELL
$121.91 - $130.94 $2.43 Million - $2.61 Million
-19,900 Reduced 2.33%
832,900 $108 Million
Q4 2022

Feb 08, 2023

SELL
$104.7 - $128.4 $5.82 Million - $7.13 Million
-55,565 Reduced 6.12%
852,800 $109 Million
Q3 2022

Nov 09, 2022

BUY
$101.65 - $119.27 $233,795 - $274,321
2,300 Added 0.25%
908,365 $95 Million
Q2 2022

Aug 09, 2022

SELL
$102.23 - $133.85 $347,582 - $455,090
-3,400 Reduced 0.37%
906,065 $95.2 Million
Q1 2022

May 09, 2022

BUY
$108.42 - $129.58 $12.5 Million - $15 Million
115,700 Added 14.58%
909,465 $116 Million
Q4 2021

Feb 08, 2022

SELL
$115.43 - $146.63 $3.58 Million - $4.55 Million
-31,000 Reduced 3.76%
793,765 $101 Million
Q3 2021

Nov 08, 2021

SELL
$136.35 - $158.76 $3.18 Million - $3.7 Million
-23,300 Reduced 2.75%
824,765 $121 Million
Q2 2021

Aug 06, 2021

BUY
$152.95 - $173.41 $7.81 Million - $8.85 Million
51,038 Added 6.4%
848,065 $136 Million
Q1 2021

May 07, 2021

BUY
$148.16 - $159.71 $2.16 Million - $2.33 Million
14,600 Added 1.87%
797,027 $128 Million
Q4 2020

Feb 05, 2021

SELL
$128.25 - $151.41 $2.89 Million - $3.41 Million
-22,500 Reduced 2.8%
782,427 $121 Million
Q3 2020

Nov 09, 2020

SELL
$113.59 - $141.68 $1.31 Million - $1.63 Million
-11,500 Reduced 1.41%
804,927 $110 Million
Q2 2020

Aug 05, 2020

BUY
$87.02 - $133.4 $1.58 Million - $2.41 Million
18,100 Added 2.27%
816,427 $97.4 Million
Q1 2020

May 08, 2020

BUY
$78.28 - $155.73 $11.8 Million - $23.5 Million
150,900 Added 23.31%
798,327 $80.7 Million
Q4 2019

Feb 06, 2020

SELL
$127.4 - $146.83 $3.68 Million - $4.24 Million
-28,900 Reduced 4.27%
647,427 $96.9 Million
Q3 2019

Nov 12, 2019

BUY
$113.33 - $138.46 $1.12 Million - $1.37 Million
9,911 Added 1.49%
676,327 $92.8 Million
Q2 2019

Aug 02, 2019

SELL
$108.87 - $125.09 $1.58 Million - $1.81 Million
-14,500 Reduced 2.13%
666,416 $78.5 Million
Q1 2019

May 10, 2019

BUY
$97.5 - $125.79 $1.89 Million - $2.44 Million
19,400 Added 2.93%
680,916 $87 Million
Q4 2018

Feb 13, 2019

BUY
$94.4 - $126.76 $1.19 Million - $1.6 Million
12,600 Added 1.94%
661,516 $68.6 Million
Q3 2018

Nov 08, 2018

SELL
$108.41 - $127.64 $2.27 Million - $2.67 Million
-20,900 Reduced 3.12%
648,916 $85.3 Million
Q2 2018

Aug 09, 2018

BUY
$102.12 - $114.04 $2.06 Million - $2.3 Million
20,200 Added 3.11%
669,816 $74.6 Million
Q1 2018

May 04, 2018

SELL
$104.31 - $124.46 $9.89 Million - $11.8 Million
-94,800 Reduced 12.73%
649,616 $70.8 Million
Q4 2017

Feb 07, 2018

BUY
$105.55 - $120.83 $105,550 - $120,830
1,000 Added 0.13%
744,416 $89.8 Million
Q3 2017

Nov 03, 2017

BUY
$106.92 - $117.79 $79.5 Million - $87.6 Million
743,416
743,416 $87 Million

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $23.2B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.